Kymera Therapeutics, Inc. (KYMR) Technical Analysis & Indicators

Kymera Therapeutics, Inc. (KYMR) — Price $127.51 (closing price, November 2, 2026) — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Technical analysis of Kymera Therapeutics, Inc. (KYMR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins.

Price Performance

1 month+17.92%
3 months+20.05%
Year-to-date+62.74%
1 year+112.04%
3 years+787.39%
5 years+94.79%

52-Week Range

52-week High$130.05
52-week Low$55.66
Avg Volume (90d)823K

Technical Indicators

SMA 50$114.92
SMA 200$96.42
Beta2.29
30-day Volatility (annualised)42.5%
Price vs SMA 50+10.2%
Price vs SMA 200+31.3%

Monthly Close (12 months)

MonthCloseChange
2025-12$77.81
2026-01$72.69-6.6%
2026-02$91.35+25.7%
2026-03$83.29-8.8%
2026-04$81.07-2.7%
2026-05$81.42+0.4%
2026-06$114.67+40.8%
2026-07$103.40-9.8%
2026-08$118.81+14.9%
2026-09$111.79-5.9%
2026-10$126.63+13.3%

Upcoming Earnings

DateEPS Est.Revenue Est.
2027-02-25$-1.30$1M
2026-10-29$-1.26$3M
2026-08-05$-0.71$33M
2026-04-30$-0.89$8M
2026-02-26$-0.78$15M
2025-11-04$-0.71$14M
2025-08-11$-0.83$17M

Price

Price$127.51 (closing price, November 2, 2026)
Market Cap$10.9B
ExchangeNASDAQ
CountryUS

Valuation Ratios

Price / Book7.91
Dividend Yield0.00%

Financial Health

Debt / Equity0.05
Current Ratio11.13
Piotroski F-Score2
Altman Z-Score23.20

Related companies: NRIX · VRTX · 0QZU.L · REGN · MRNA · 0R2M.L · ARGX · 0QNO.L

Explore sector: Healthcare · Biotechnology

More sections of KYMR: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks